Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

187.55
BATS BZX Real-Time Price
As of 10:59am ET
 +1.23 / +0.66%
Today’s Change
133.64
Today|||52-Week Range
191.10
+28.27%
Year-to-Date
Biotech Stock Roundup: FDA Nod for First Cancer Biosimilar, HALO up on Deals, Raised ...
9:18am / Zacks.com - Paid Partner Content
Amgen/Allergan's Avastin Biosimilar Secures FDA Approval
Sep 15 / Zacks.com - Paid Partner Content
Is Amgen (AMGN) a Great Stock for Value Investors?
Sep 19 / Zacks.com - Paid Partner Content
FDA Approves First 'Biosimilar' for Cancer Treatment
Sep 14 / TheStreet.com - Paid Partner Content
Novartis Announces Positive Data on Urticaria Drug Xolair
Sep 18 / Zacks.com - Paid Partner Content
Biosimilar 2017 Progress Report: Stocks in Focus
Sep 14 / Zacks.com - Paid Partner Content
Allergan's Restasis Patent Transfer to Face Precedent-Setting Legal Battle
Sep 16 / TheStreet.com - Paid Partner Content
Novartis' BLA for Biosimilar of Rituxan Accepted by the FDA
Sep 12 / Zacks.com - Paid Partner Content
Top Research Reports for Philip Morris, Amgen & Union Pacific
Sep 15 / Zacks.com - Paid Partner Content
AbbVie's RA Candidate Meets Primary Endpoint in Phase III
Sep 12 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close186.32
Today’s open187.17
Day’s range186.37 - 188.48
Volume19,315
Average volume (3 months)2,991,524
Market cap$136.0B
Dividend yield2.45%
Data as of 10:59am ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+7.82%
Earnings growth (next 5 years)+3.73%
Revenue growth (last year)+6.31%
P/E ratio17.1
Price/Sales4.86
Price/Book4.60

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences+0.22+0.27%
BIIBBiogen+1.81+0.57%
ILMNIllumina Inc-2.73-1.33%
KITEKite Pharma Inc-0.22-0.12%
Data as of 10:59am ET, 09/20/2017

Financials

Next reporting dateOctober 24, 2017
EPS forecast (this quarter)$3.10
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts